North Star Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

North Star Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,000	Closed	-$201K	–	349
2025 Q3	$201K	Buy	+5,000	New	+$188K	0.01%	335
2024 Q4	–	Sell	-5,000	Closed	-$222K	–	322
2024 Q3	$222K	Hold	5,000	–	–	0.01%	298
2024 Q2	$216K	Buy	+5,000	New	+$180K	0.01%	290
2021 Q4	–	Sell	-5,600	Closed	-$258K	–	315
2021 Q3	$258K	Hold	5,600	–	–	0.01%	264
2021 Q2	$309K	Hold	5,600	–	–	0.02%	248
2021 Q1	$289K	Hold	5,600	–	–	0.02%	239
2020 Q4	$243K	Buy	+5,600	New	+$221K	0.02%	249
2020 Q3	–	Sell	-5,600	Closed	-$299K	–	252
2020 Q2	$299K	Buy	+5,600	New	+$259K	0.02%	212
2020 Q1	–	Sell	-5,600	Closed	-$267K	–	249
2019 Q4	$267K	Buy	+5,600	New	+$212K	0.02%	247
2019 Q3	–	Sell	-5,600	Closed	-$279K	–	286
2019 Q2	$279K	Hold	5,600	–	–	0.02%	241
2019 Q1	$378K	Hold	5,600	–	–	0.03%	219
2018 Q4	$258K	Hold	5,600	–	–	0.02%	237
2018 Q3	$432K	Hold	5,600	–	–	0.03%	214
2018 Q2	$472K	Hold	5,600	–	–	0.04%	207
2018 Q1	$458K	Hold	5,600	–	–	0.04%	205
2017 Q4	$320K	Buy	+5,600	New	+$352K	0.03%	232

Other funds holding AGIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

North Star Asset Management's AGIO Position: Q4 2025 in Review

North Star Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2025, closing a stake of 5,000 shares — an estimated $201K sold.

North Star Asset Management first reported a position in AGIO in Q4 2017 and held it in 16 quarters. The position peaked at $472K in Q2 2018. 238 funds tracked by Wall St. Rank hold AGIO as of Q4 2025.

North Star Asset Management reported no remaining Agios Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
North Star Asset Management sold 5,000 Agios Pharmaceuticals shares in Q4 2025, an estimated $201K.
North Star Asset Management first reported a position in Agios Pharmaceuticals in Q4 2017 and held it in 16 quarters.
North Star Asset Management's Agios Pharmaceuticals position peaked at $472K in Q2 2018.
238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2025.

Based on North Star Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.